Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

At the 2020 Annual Meeting of Stockholders ("Annual Meeting") of Cantel Medical Corp. (the "Company") held on December 16, 2020, the Company's stockholders approved the Cantel Medical. Corp. 2020 Equity Incentive Plan ("2020 Equity Plan"). The terms of the 2020 Equity Plan are described in the Company's definitive proxy statement , which was filed with the Securities and Exchange Commission on November 18, 2020 and s u pp lemente d on November 30, 2020 (the "Proxy Statement"), which description is incorporated herein by reference. The 2020 Equity Plan was included as Anne x A to the Proxy Statement and is incorporated by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders

At the Annual Meeting, four proposals were voted on by the Company's stockholders. The proposals are described in detail in the Proxy Statement in connection with the Annual Meeting and summarized below.

A final voting report was produced by Broadridge Financial Solutions, Inc., the independent inspector of election for the Annual Meeting, certifying the results on the four proposals: Proposal 1 The stockholders elected all ten director nominees to serve as members of the Company's board of directors until the Company's 2021 Annual Meeting of Stockholders.


        Name                 For            Against        Abstain        Broker Non-Votes
Alan R. Batkin            34,317,512        588,587        24,010            4,369,841
Ann E. Berman             34,715,138        191,321        23,650            4,369,841
Charles M. Diker          34,500,347        406,115        23,647            4,369,841
Mark N. Diker             34,598,572        305,844        25,693            4,369,841
Anthony B. Evnin          30,813,517       4,091,548       25,044            4,369,841
Laura L. Forese           30,801,593       4,104,564       23,952            4,369,841
George L. Fotiades        34,352,635        552,864        24,610            4,369,841
Ronnie Myers              34,724,392        180,650        25,067            4,369,841
Karen N. Prange           34,428,026        478,533        23,550            4,369,841
Peter J. Pronovost        30,840,636       4,065,364       24,109            4,369,841

Proposal 2 The stockholders approved, on an advisory basis, the compensation of the Company's Named Executive Officers.


     For            Against        Abstain        Broker Non-Votes
  34,448,451        441,074        40,584            4,369,841



Proposal 3 The stockholders approved the Cantel Medical Corp. 2020 Equity
Incentive Plan.

     For            Against        Abstain        Broker Non-Votes
  34,285,311        621,946        22,852            4,369,841

Proposal 4 The stockholders ratified the appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending July 31, 2021.


     For            Against        Abstain
  39,247,538        25,898         26,514

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses